Cargando…

A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence

Non-Alcoholic Fatty Liver Disease (NAFLD) is now the most prevalent form of chronic liver disease, affecting 10%–20% of the general paediatric population. Within the next 10 years it is expected to become the leading cause of liver pathology, liver failure and indication for liver transplantation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Temple, Jonathan L., Cordero, Paul, Li, Jiawei, Nguyen, Vi, Oben, Jude A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926480/
https://www.ncbi.nlm.nih.gov/pubmed/27314342
http://dx.doi.org/10.3390/ijms17060947
_version_ 1782440123050229760
author Temple, Jonathan L.
Cordero, Paul
Li, Jiawei
Nguyen, Vi
Oben, Jude A.
author_facet Temple, Jonathan L.
Cordero, Paul
Li, Jiawei
Nguyen, Vi
Oben, Jude A.
author_sort Temple, Jonathan L.
collection PubMed
description Non-Alcoholic Fatty Liver Disease (NAFLD) is now the most prevalent form of chronic liver disease, affecting 10%–20% of the general paediatric population. Within the next 10 years it is expected to become the leading cause of liver pathology, liver failure and indication for liver transplantation in childhood and adolescence in the Western world. While our understanding of the pathophysiological mechanisms underlying this disease remains limited, it is thought to be the hepatic manifestation of more widespread metabolic dysfunction and is strongly associated with a number of metabolic risk factors, including insulin resistance, dyslipidaemia, cardiovascular disease and, most significantly, obesity. Despite this, ”paediatric” NAFLD remains under-studied, under-recognised and, potentially, undermanaged. This article will explore and evaluate our current understanding of NAFLD in childhood and adolescence and how it differs from adult NAFLD, in terms of its epidemiology, pathophysiology, natural history, diagnosis and clinical management. Given the current absence of definitive radiological and histopathological diagnostic tests, maintenance of a high clinical suspicion by all members of the multidisciplinary team in primary and specialist care settings remains the most potent of diagnostic tools, enabling early diagnosis and appropriate therapeutic intervention.
format Online
Article
Text
id pubmed-4926480
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-49264802016-07-06 A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence Temple, Jonathan L. Cordero, Paul Li, Jiawei Nguyen, Vi Oben, Jude A. Int J Mol Sci Review Non-Alcoholic Fatty Liver Disease (NAFLD) is now the most prevalent form of chronic liver disease, affecting 10%–20% of the general paediatric population. Within the next 10 years it is expected to become the leading cause of liver pathology, liver failure and indication for liver transplantation in childhood and adolescence in the Western world. While our understanding of the pathophysiological mechanisms underlying this disease remains limited, it is thought to be the hepatic manifestation of more widespread metabolic dysfunction and is strongly associated with a number of metabolic risk factors, including insulin resistance, dyslipidaemia, cardiovascular disease and, most significantly, obesity. Despite this, ”paediatric” NAFLD remains under-studied, under-recognised and, potentially, undermanaged. This article will explore and evaluate our current understanding of NAFLD in childhood and adolescence and how it differs from adult NAFLD, in terms of its epidemiology, pathophysiology, natural history, diagnosis and clinical management. Given the current absence of definitive radiological and histopathological diagnostic tests, maintenance of a high clinical suspicion by all members of the multidisciplinary team in primary and specialist care settings remains the most potent of diagnostic tools, enabling early diagnosis and appropriate therapeutic intervention. MDPI 2016-06-15 /pmc/articles/PMC4926480/ /pubmed/27314342 http://dx.doi.org/10.3390/ijms17060947 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Temple, Jonathan L.
Cordero, Paul
Li, Jiawei
Nguyen, Vi
Oben, Jude A.
A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
title A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
title_full A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
title_fullStr A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
title_full_unstemmed A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
title_short A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
title_sort guide to non-alcoholic fatty liver disease in childhood and adolescence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926480/
https://www.ncbi.nlm.nih.gov/pubmed/27314342
http://dx.doi.org/10.3390/ijms17060947
work_keys_str_mv AT templejonathanl aguidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT corderopaul aguidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT lijiawei aguidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT nguyenvi aguidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT obenjudea aguidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT templejonathanl guidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT corderopaul guidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT lijiawei guidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT nguyenvi guidetononalcoholicfattyliverdiseaseinchildhoodandadolescence
AT obenjudea guidetononalcoholicfattyliverdiseaseinchildhoodandadolescence